Received May 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | 3004171 | PO / MO |
5/2/25: Dose #1, no significant side effects 5/4/25: Dose #2 - approximately 90 minutes after taking, began experiencing a rash on her face, itchiness on both hands, and "mild hives" on one hand. Denies dyspnea, wheezing, or swelling. Went to sleep and those symptoms were resolved by the morning without intervention. The morning of 5/5, pt experience stomach pain and nausea, which became more severe by bedtime. Took Tums and Pepto Bismol. Today, pt continues to have some pain, but reports it is less severe than yesterday. Advised pt to stop taking. Continued to have stomach discomfort for 2 more days, but improved each day.
none
none
none
none
N/A